{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-000906","form_type":"8-K","ticker":"ADMA","cik":"0001368514","company_name":"ADMA BIOLOGICS, INC.","filed_at":"2026-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.924847+00:00","generated_at":"2026-05-16T10:48:44.384764+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"ADMA prelim FY2025 rev ~$510-511M, raises FY2026 rev/EBITDA guidance, targets >$1.1B by 2029","bullets":["Preliminary FY2025 total revenue ~$510-511M, meeting or exceeding prior guidance. Cash grew to ~$88M with ~$40M Q4 operating cash flow.","FY2026 revenue guidance raised to ~$635M (from $630M); FY2026 adjusted EBITDA raised to ~$360M (from $355M). Adjusted net income reiterated at ~$255M.","FY2027 revenue guided ~$775M, adjusted net income ~$315M, adjusted EBITDA ~$455M.","Long-term targets: >$1.1B revenue and >$700M adjusted EBITDA by FY2029. Yield-enhanced production now routine, 2026 first full year of monetization.","Divested three plasma centers for $12M, secured long-term supply agreements, expects accretive cost savings from strategic repositioning."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-000906","json":"https://secwatch.observer/filing/0001140361-26-000906.json","markdown":"https://secwatch.observer/filing/0001140361-26-000906.md","text":"https://secwatch.observer/filing/0001140361-26-000906.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1368514/000114036126000906/0001140361-26-000906-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1368514/000114036126000906/ef20062685_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:48:44.384764+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}